OUR SCIENTIFIC STRATEGY
Our approach to developing candidates for enhanced healthspan and lifespan is based on naturally occurring molecules that provide high-potential solutions to the challenges of cellular degeneration.

We focus on in-human testing of improved and original solutions for the cellular dysfunction and damage which results in the aging process.

Our priority research and development program is NAD+ optimization, and our current primary focus is nicotinamide mononucleotide (NMN).

We are harnessing the enormous potential of the NMN molecule

to address cellular health and energy in three key ways:

Advancing
Advancing a unique, high purity form of NMN called NMN-C® and other synergetic molecules to optimize NAD+ metabolism.
Accelerating
Accelerating potential new NMN-based formulations to support a range of products targeting energy, well-being and longevity.
Undertaking
Undertaking a comprehensive clinical trial program which aims to prove the health and energy benefits of NMN in humans.
OUR SCIENTIFIC STRATEGY
Our approach to developing candidates for enhanced healthspan and lifespan is based on naturally occurring molecules that provide high-potential solutions to the challenges of cellular degeneration.

We focus on testing in humans improved and original solutions for the cellular dysfunction and damage which results in the aging process.

Our priority research and development program is NAD+ optimization, and our current primary focus is nicotinamide mononucleotide (NMN).

We are harnessing the enormous potential of the NMN molecule

to address cellular health and energy in three key ways:

Advancing
Advancing a unique, high purity form of NMN called NMN-C® and other synergetic molecules
to optimize NAD+ metabolism.
Accelerating
Accelerating potential new NMN-based formulations
to support a range of products targeting energy,
well-being and longevity.
Undertaking
Undertaking a comprehensive clinical trial program which aims to prove the health and energy benefits
of NMN in humans.